SCHEMBL25835354

SCHEMBL25835354

COc1ccc(C2=CC(=O)[C@H](O)CC2=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.50
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 2/20 0.46
MAPK1 P28482 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 2/20 0.46
PKM P14618 1/20 0.46
MCL1 Q07820 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PTPN1 P18031 1/20 0.42
ME2 P23368 1/20 0.40
ME1 P48163 1/20 0.40
ME3 Q16798 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ESR2 Q92731 1/20 0.38
HPGD P15428 1/20 0.38
MAP2K1 Q02750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25835356 0.82 HDAC4 (0.46) ALDH1A1HDAC4HDAC8GAABRD4
SCHEMBL25835355 0.80 PTPRC (0.35) MEN1MAPK1KMT2AMAPTALDH1A1
SCHEMBL25836945 0.79 PTGS2 (0.35) KDM4EMAPTALDH1A1SMN1; SMN2HPGD
SCHEMBL25835351 0.78 BACE1 (0.39) BACE1KDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL25834695 0.74 BACE1 (0.53) BACE1KDM4EMEN1MAPK1KMT2A
SCHEMBL25835385 0.73 L3MBTL1 (0.46) KDM4EMEN1KMT2AMAPTTDP1
SCHEMBL25835376 0.71 TDP2 (0.34) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL25836490 0.71 ME2 (0.46) BACE1KDM4EMEN1MAPK1KMT2A
SCHEMBL2721721 0.65 BACE1 (0.53) BACE1KDM4EMEN1MAPK1KMT2A
SCHEMBL10778347 0.64 RAB9A (0.46) MEN1KMT2AALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES THE UNIVERSITY OF HONG KONG (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES NFE2L2, DUOX1, DUOX2 BACE1 608/4885KDM4E 3115/4885MEN1 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.